Praxis Reinfeld Mitte
- Address
- lock Available on a paid plan
Praxis Reinfeld Mitte - Cardiovascular and Infectious Disease Research
Praxis Reinfeld Mitte is a clinical research facility with expertise in evaluating novel therapeutic interventions for cardiovascular disease and infectious disease prevention. The center conducts Phase 3 clinical trials focused on addressing critical unmet medical needs in patient populations requiring advanced treatment strategies.
- Atherosclerotic cardiovascular disease and lipid management therapies
- Prevention of major adverse cardiovascular events including myocardial infarction and stroke
- Vaccine development for invasive extraintestinal pathogenic E. coli infections
The center's research portfolio includes investigation of lipid-modifying therapies for patients with inadequate response to current treatments, as well as preventive vaccine strategies targeting invasive E. coli disease in vulnerable populations such as older adults with recurrent urinary tract infections. This dual focus on cardiovascular and infectious disease research positions the center at the forefront of evaluating innovative interventions aimed at reducing cardiovascular mortality and preventing serious bacterial infections in high-risk patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1AstraZeneca AB2active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB4trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Praxis Reinfeld Mitte
lock Showing 1 of 17 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A prospective, multi-centre, randomised, double-blind, placebo-controlled Phase III trial to investigate the efficacy and safety of lozenges with benzydamine hydrochloride and dichlorobenzyl alcohol in the symptomatic treatment of patients suffering from acute pharyngitis | MEDICE Arzneimittel Puetter GmbH & Co. KG | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Baxdrostat | 4 | Unknown | 2024-06-05 | 2025-09-19 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.